A team from Mass General Hospital has developed modified criteria to improve the identification of anaphylaxis in infants and toddlers, a group historically difficult to diagnose. The research, published in the Journal of Allergy and Clinical Immunology: In Practice, calls for training clinicians to recognize and manage anaphylaxis in young patients. The team’s criteria was able to identify 98% of anaphylaxis cases, notably higher than the current national standard’s 85% rate.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
